Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|September 18, 2020
Transvenous phrenic nerve stimulation to treat idiopathic central sleep apneaShahrokh Javaheri, Scott McKaneSleep|June 7, 2023
Transvenous phrenic nerve stimulation is associated with normalization of nocturnal heart rate perturbations in patients with central sleep apneaMathias Baumert, Dominik Linz, Scott McKane, et al.Sleep & Breathing = Schlaf & Atmung|July 31, 2024
Phrenic nerve stimulation for central sleep apnea: a single institution experienceJulie Mease, Ralph Augostini, Scott McKane, et al.International Journal of Cardiology|February 25, 2023
Transvenous phrenic nerve stimulation for the treatment of central sleep apnea reduces episodic hypoxemic burdenMathias Baumert, Sarah Immanuel, Scott McKane, et al.Sleep & Breathing = Schlaf & Atmung|July 12, 2023
Analysis by sex of safety and effectiveness of transvenous phrenic nerve stimulationSoraya Samii, Scott McKane, Timothy E Meyer, et al.European Journal of Cardiovascular Nursing|September 20, 2022
Transvenous phrenic nerve stimulation to treat central sleep apnoea in patients with heart failure may improve sleep, quality of life, and symptomsLoreena Hill, Timothy Meyer, Scott McKane, et al.Sleep & Breathing = Schlaf & Atmung|March 21, 2021
Transvenous phrenic nerve stimulation improves central sleep apnea, sleep quality, and quality of life regardless of prior positive airway pressure treatmentAlan R Schwartz, Lee R Goldberg, Scott McKane, et al.Sleep Medicine|November 21, 2023
Transvenous phrenic nerve stimulation for treating central sleep apnea may regulate sleep microstructureSimon Hartmann, Sarah Immanuel, Scott McKane, et al.Journal of Cardiovascular Translational Research|August 14, 2020
Improving Nocturnal Hypoxemic Burden with Transvenous Phrenic Nerve Stimulation for the Treatment of Central Sleep ApneaOlaf Oldenburg, Maria Rosa Costanzo, Robin Germany, et al.Archives of Dermatology|April 20, 2005
Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trialsNeil Korman, Ron Moy, Mark Ling, et al.Pageof 3